I think oncologists are very concerned that the treatments they give to patients are actually going to improve their health. As we learn more about the growing costs of cancer care, the burden on patient copay, we’re looking at, “Do we really understand the full impact of the treatment we’re giving to patients?”
That really means the outcome as far as progression‑free survival and overall survival, as well as the toxicities, the side effects, the costs of those, and the costs of the overall regimen to the patient.
